Frontiers journals are at the top of citation and impact metrics
Frontiers in Translational Pharmacology publishes original and review articles on the most outstanding advances across the spectrum of research that is undertaken to from drug discovery to market. We consider Translational Pharmacology as a two-way road: bench to bedside and bedside to bench. This concept, initiated in 2003 in translational medicine, is increasingly important in Pharmacological Research and Development. Articles for submission may present studies that validate drug targets or describe pharmacological characterization of known or novel compounds. The full suite of development activities is of interest, especially those concerning the relationship between pharmacokinetics and pharmacodynamics. Articles addressing safety, efficacy, toxicology and toxicokinetics are within the scope of the specialty section. Studies dealing with drug formulation and delivery may be considered when these are integrated with biological studies. This section has a specific interest in promoting the use of organ- and disease-on-a-chip and related 3 dimensional in vitro models of chronic diseases. Studies dealing with the application of mechanical inputs and outputs in assessment of drug actions, as well as those on agents impacting on cellular and molecular mechanics will be identified in an emerging sub-discipline of “Mechanopharmacology”. The overall goal of Translational Pharmacology is to build a research platform and to inform and educate the scientific community on current developments and approaches to translation of knowledge on drug targets into new medicines.
Indexed in: PubMed, PubMed Central, Scopus, Web of Science, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS)
PMCID: all published articles receive a PMCID
Translational Pharmacology welcomes submissions of the following article types: Book Review, Case Report, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge and Technology Report.
All manuscripts must be submitted directly to the section Translational Pharmacology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Translational Pharmacology will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Pharmacology.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com